| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |